Platinum Longevity Trip
San Francisco & San Diego
September 11-15 or October 9-13, 2024
Event Overview
Join Peter H. Diamandis, MD and a small, exclusive group of 40 participants (investors, leaders, and CEOs) on this luxury 5-day trip exploring the future of health. Explore a deep dive into longevity, age reversal, healthspan, and immunity, including key therapies, research, and novel breakthroughs that will define the next decade of longevity.
The trip offers first-hand exposure to the pioneering founders, scientists, Nobel Laureates, startups, public biotech companies, and treatments in longevity and vitality. We’ll explore topics such as weight loss, microbiome, reproductive health, organ regeneration, cancer, infectious diseases, AI & drug discovery, CRISPR & gene editing, gene therapy, epigenetic reprogramming, and many more. Gain an exclusive view of what is coming our way this next decade in personalized, preventive medicine, and rejuvenation treatments.
The Basics (Sleep, Diet, Exercise, Meditation)
Gene Therapy & Epigenetic Reprogramming
Regenerative Medicine Therapies
AI & Drug Discovery
Cancer / Oncology
Inflammation / Autoimmune Disorders
Infectious Diseases
Reproductive Health
Weight Loss / Diabetes
Day 2: Hear from the world’s leading longevity researchers and entrepreneurs onsite at the Platinum Lounge, network with other attendees, and enjoy a speaker dinner with the Gladstone Institutes.
Day 3: Travel to the Buck Institute, attend a private dinner, and collaborate on a mastermind debrief session.
Day 4: Private transfer to San Diego. Arrive at the 5-star hotel for continued programming with prestigious labs and institutes.
Day 5: Hear from more top longevity speakers, explore investment opportunities, and join for a closing dinner.
Melanie Ott, MD, PhD
Director, Gladstone Institute of Virology
David Sinclair, PhD
Co-Director, Glenn Center for Aging Research, Professor at Harvard Medical School
Eric Verdin, MD
President and CEO, Buck Institute for Research on Aging
George Church, PhD
Founding Core Faculty & Lead, Wyss Institute at Harvard University
Mary Lou Jepsen, PhD
CEO and Founder, OpenWater
Shinya Yamanaka, MD, PhD
Nobel Prize laureate & L.K. Whittier Foundation Investigator in Stem Cell Biology, Gladstone Institutes
Jennifer Garrison, PhD
Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality
Sandra Kaufmann, MD
Author and Creator of the Kaufmann Protocol
Timothy Nelson, MD, PhD
Founder & CEO, Heartworks
Alessandra Zonari, PhD
Co-Founder and Chief Scientific Officer, OneSkin
Robin Mansukhani
CEO and Co-Founder, Deciduous Therapeutics
Kyle Zagrodsky
Founder & CEO, OsteoStrong Franchising
Joshua Ofman, MD, MSHS
President and Chief Medical Officer
Daniel Kraft, MD
Founder & Chair, Exponential Medicine
Josh Clemente
Founder, Levels
Jon Carder
Co-Founder & CEO, Vessel Health
Trevor Martin, PhD
Co Founder, Mammoth Biosciences
Kristen Fortney, PhD
Co Founder and CEO, BioAge
Naveen Jain
Author, Moonshots: Creating a World of Abundance
Morgan Levine, PhD
Founding Principal Investigator, Altos Labs
Daniel Oliver
Co Founder and CEO, Rejuvenate Bio
Dean Ornish, MD
Founder and President, Preventive Medicine Research Institute
Priya Abani
CEO, President, and Board Member, AliveCor
James Min, MD
Founder and CEO, Cleerly
Katerina Akassoglou, PhD
Professor of Neurology, UC San Francisco (UCSF)
Yadong Huang, MD, PhD
Scientific Co-Founder, GABAeron
James Nestor
Science Journalist and Author, Breath
Tara Tracy, PhD
Assistant Professor, Buck Institute for Research on Aging
Seth Shipman, PHD
Assistant Professor, Gladstone Institutes at UCSF
George Shapiro, MD
Chief Medical Innovation Officer, Fountain Life
Matt Walker, PhD
Professor, UC Berkeley
Bjoern Woltermann
Founder & CEO, Katalyst
Denitsa Milanova, PhD
Fellow & PI, Marble Therapeutics
Sandeep Akkaraju
CEO & President, Exo Imaging
Greg Bailey, MD
CEO, Juvenescence
Carolina Reis
CEO, OneSkin
Leor Weinberger, PhD
Co-Founder, VxBiosciences
John Jaquish, PhD
Inventor, OsteoStrong Devices
Kenneth R. Brown, DDS
Co-Founder & CEO, Feno
David Furman, PhD
Associate Professor, Buck Institute for Research on Aging
Isha Jain, PhD
Assistant Professor, Gladstone Institutes and UCSF
Kyle Zagrodzky
Founder & CEO, OsteoStrong Franchising
Deepak Srivastava, MD
President, Gladstone Institutes
David Fagjenbaum, MD
Physician-Scientist, University of Pennsylvania
Brianna Stubbs, PhD
Lead Translational Scientist, Buck Institute for Research on Aging
Noah Davidsohn, PhD
CSO, Co-Founder, Rejuvenate Bio
Kent Wakeford
Co Founder, Chief Operating Officer, Colossal
Alex Aravanis, MD, PhD
Chief Technology Officer, Illumina
Remy Gross III
Vice President, Business Development and Technology Advancement, Buck Institute for Research on Aging
About Peter H. Diamandis, MD
Peter Diamandis is a serial entrepreneur, futurist, technologist, TED Speaker, New York Times Bestselling Author, and the founder of over 20 ventures, including Celularity, Human Longevity Inc., BOLD Capital Partners, and XPRIZE Foundation. Fortune magazine has named Peter one of the World’s 50 Greatest Leaders. He earned degrees in Molecular Genetics and Aerospace Engineering from MIT, and an MD from Harvard Medical School.
Peter’s mission is to transform your mindset around longevity - to give you overwhelming evidence of the massive medical advancements that are already beginning to extend the human healthspan.